TrialRheumatology (Oxford, England)2011

Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.